Trust Company of Toledo’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
44,986
+1,546
+4% +$333K 0.94% 23
2026
Q1
$9.45M Sell
43,440
-94
-0.2% -$20.9K 0.9% 25
2025
Q4
$9.95M Buy
43,534
+947
+2% +$216K 0.98% 20
2025
Q3
$9.86M Buy
42,587
+38
+0.1% +$7.74K 0.99% 21
2025
Q2
$7.9M Buy
42,549
+89
+0.2% +$16.5K 0.87% 25
2025
Q1
$8.9M Sell
42,460
-55
-0.1% -$10.7K 1.18% 18
2024
Q4
$7.55M Sell
42,515
-17
-0% -$3.13K 0.99% 24
2024
Q3
$8.4M Buy
42,532
+681
+2% +$127K 1.14% 18
2024
Q2
$7.18M Buy
41,851
+931
+2% +$154K 1.04% 24
2024
Q1
$7.45M Sell
40,920
-656
-2% -$113K 1.17% 23
2023
Q4
$6.44M Sell
41,576
-570
-1% -$83.1K 1.11% 24
2023
Q3
$6.28M Sell
42,146
-5
-0% -$734 1.24% 20
2023
Q2
$5.68M Sell
42,151
-1,258
-3% -$184K 0.96% 26
2023
Q1
$6.92M Buy
43,409
+1,411
+3% +$216K 1.23% 16
2022
Q4
$6.79K Buy
41,998
+729
+2% +$112K 1.28% 18
2022
Q3
$5.54M Sell
41,269
-7,649
-16% -$1.1M 1.07% 22
2022
Q2
$7.49M Sell
48,918
-151
-0.3% -$23.1K 1.31% 15
2022
Q1
$7.95M Buy
49,069
+130
+0.3% +$18.9K 1.22% 18
2021
Q4
$6.63M Sell
48,939
-366
-0.7% -$43.2K 0.99% 26
2021
Q3
$5.32M Sell
49,305
-593
-1% -$67.8K 0.87% 29
2021
Q2
$5.62M Sell
49,898
-448
-0.9% -$50.5K 0.95% 28
2021
Q1
$5.45M Sell
50,346
-141
-0.3% -$15.1K 0.98% 28
2020
Q4
$5.41M Buy
50,487
+968
+2% +$93K 1.05% 25
2020
Q3
$4.34M Sell
49,519
-80
-0.2% -$7.53K 0.97% 26
2020
Q2
$4.87M Buy
49,599
+1,392
+3% +$123K 1.16% 22
2020
Q1
$3.67M Sell
48,207
-1,002
-2% -$85.3K 1.01% 27
2019
Q4
$4.36M Sell
49,209
-166
-0.3% -$13.8K 1.02% 27
2019
Q3
$3.74M Sell
49,375
-4,006
-8% -$275K 0.91% 28
2019
Q2
$3.88M Buy
53,381
+23
+0% +$1.81K 0.97% 29
2019
Q1
$4.3M Sell
53,358
-817
-2% -$66.8K 1.1% 28
2018
Q4
$4.99M Buy
54,175
+1,330
+3% +$117K 1.4% 16
2018
Q3
$5M Sell
52,845
-3,471
-6% -$329K 1.27% 17
2018
Q2
$5.22M Sell
56,316
-158
-0.3% -$15.4K 1.39% 13
2018
Q1
$5.34M Sell
56,474
-489
-0.9% -$53.7K 1.41% 13
2017
Q4
$5.51M Sell
56,963
-200
-0.3% -$18.8K 1.37% 15
2017
Q3
$5.08M Sell
57,163
-293
-0.5% -$22.3K 1.29% 17
2017
Q2
$4.17M Buy
57,456
+7,575
+15% +$509K 1.08% 24
2017
Q1
$3.25M Buy
49,881
+348
+0.7% +$21.9K 0.89% 28
2016
Q4
$3.1M Sell
49,533
-2
-0% -$122 0.87% 30
2016
Q3
$3.12M Sell
49,535
-325
-0.7% -$21K 0.89% 27
2016
Q2
$3.09M Sell
49,860
-1,539
-3% -$93.8K 0.89% 28
2016
Q1
$2.94M Sell
51,399
-75
-0.1% -$4.18K 0.88% 32
2015
Q4
$3.05M Sell
51,474
-89
-0.2% -$5.13K 0.94% 28
2015
Q3
$2.81M Buy
51,563
+369
+0.7% +$24K 0.89% 28
2015
Q2
$3.44M Buy
51,194
+1,635
+3% +$107K 1% 22
2015
Q1
$2.9M Sell
49,559
-287
-0.6% -$17.3K 0.87% 25
2014
Q4
$3.26M Sell
49,846
-450
-0.9% -$28.4K 0.99% 20
2014
Q3
$2.9M Sell
50,296
-775
-2% -$43K 0.96% 23
2014
Q2
$2.88M Hold
51,071
0.85% 25
2014
Q1
$2.63M Sell
51,071
-3,558
-7% -$180K 0.8% 30
2013
Q4
$2.88M Sell
54,629
-424
-0.8% -$20.8K 0.93% 20
2013
Q3
$2.46M Sell
55,053
-10,827
-16% -$480K 0.88% 21
2013
Q2
$2.72M Buy
+65,880
New +$2.88M 1.01% 20

Other funds holding ABBV

Trust Company of Toledo's ABBV Position: Q2 2026 in Review

Trust Company of Toledo increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $333K and bringing the position to 44,986 shares worth $11.3M. The position accounts for 0.94% of the portfolio, ranked #23.

Trust Company of Toledo first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trust Company of Toledo held 44,986 shares of AbbVie worth $11.3M as of Q2 2026.
  • Trust Company of Toledo bought 1,546 AbbVie shares in Q2 2026, an estimated $333K.
  • AbbVie made up 0.94% of Trust Company of Toledo's portfolio in Q2 2026, its #23 holding.
  • Trust Company of Toledo first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.